Detalles de la búsqueda
1.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 164(3): 649-658, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28508185
2.
Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors.
Clin Cancer Res
; 8(9): 2828-34, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12231523
3.
First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.
Clin Lymphoma
; 4(1): 36-42, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12837153
4.
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Springerplus
; 3: 244, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24860718
5.
Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.
J Oncol Pract
; 10(1): 39-45, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24443733
6.
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
Oncologist
; 9(6): 644-52, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15561808
Resultados
1 -
6
de 6
1
Próxima >
>>